Integrated ABPM and Pulse Wave Analysis underlines I.E.M.'s technology leadership
Stolberg (Germany): I.E.M. announced to launch their integrated pulse wave analysis (PWA) Solution as an upgrade to their well proven ambulatory 24-hour blood pressure monitoring system Mobil-O-Graph NG. This new feature has been developed together with ARC (Austrian Research Centers) and once again underlines I.E.M.'s claim as technology leader in the field of hypertension management.
For the accurate diagnosis of hypertension, measurements of blood pressure as well as the analysis of pulse wave are crucial. As a first result of the cooperation with the Austrian Research Centers - Austria's largest research organization for applied research – I.E.M. has integrated pulse wave analysis algorithms with their well known ambulatory blood pressure monitor device (Mobil-O-Graph NG®). Until now, pulse wave devices were (due to their high cost) previously reserved exclusively for hospitals. Thanks to the I.E.M. technology, the PWA cost has come down far enough to make this diagnostic available to cardiologists, internists and general physicians and thus a large number of patients as a standard diagnostic procedure. Previously it was assumed that the blood pressure on the arm reflects the pressure in other parts of the body. But studies show that the pressure measurement to the aorta by the simple standard method of measuring blood pressure, supplemented by the pulse wave, is a more accurate and more appropriate method to find a better prognosis for the blood pressure therapy and control of hypertensive patients. To manage arterial hypertension and diagnose potential damage of the arterial system early, the European Society of Hypertension Congress in 2007 strongly recommended the analysis of pulse wave as part of the evaluation of hypertensive patients. The implementation of pulse wave analysis in the standard diagnostic protocol for hypertensive patients is the logical result of the outcome of the Conduit Artery Functional Evaluation (CAFE) study. Despite similar brachial systolic blood pressures within the study results, amlodipine-based treatment was more effective than atenolol-based treatment at lowering central aortic systolic blood pressure and central aortic pulse pressure, which were proven to closely correlate with the probability of future CV events among study participants.
I.E.M. GmbH - Cockerillstr. 69 - D-52222 Stolberg - Germany
All I.E.M. devices provide their collected data via the Bluetooth communication standard to a mobile phone or modem without user interaction necessary. In accordance with the high European standards of data security and encryption, the information is transferred automatically via the mobile phone network to an electronic medical record. Medical Doctors and patients are able to receive alerts via e-mail, facsimile, letter or short message service SMS.
About I.E.M.
I.E.M. GmbH, founded 1993 in Stolberg/Germany, is a worldwide recognized specialist for blood pressure management, sensor and communication technology, e-health databases and electronic medical records. The product range focus is on medical monitoring equipment for weight, long term and mobile blood pressure measurement. I.E.M. cooperates with patient care givers and health insurance companies in several countries. The latest product, a PWA analysis solution was jointly developed with the Austrian Research Center in Vienna. More than 40,000 Medical Doctors and 500,000 patients worldwide trust in I.E.M. products and solutions. For more information contact: I.E.M. GmbH
Cockerillstr. 69 - D-52222 Stolberg, Germany Tel: +49 2402 95 000 - Fax: +49 2402 95 00 11 Internet:
I.E.M. GmbH - Cockerillstr. 69 - D-52222 Stolberg - Germany
FU GENERALIZED PAIN TEST Chart # DOB: PRESENT ILLNESS INFORMATION Chief Complaint: S1: Patient presents for a pain management follow-up. Doing very well currently. Legs will still hurt in the evening so she sits and rests. She picks up her grandkids from school every day. Rates her pain today tolerable.She reports good relief with current treatment plan. Her activities have increased a
PHARMACEUTICAL SALESTOveRrlanEd PYark , RKaEnsaYs 6N621O4 Catering April, 2013 to Present Operations and Sales with experience in the Restaurant and Hospitality industries. Catering and food servicesfor corporations, individual and multiple clientele, and private engagements. Past sales and managerial experience in the adult beverage industry, al ows for advanced and immediateresponsibility in